Investorideas.com breaking new for AI and tech stocks

Monday, March 4, 2019

The #AIEye: #IBMWatson ( $IBM) Health Publishes Top 100 Hospitals List, NICE Expands Partnership with ABBYY and MYnd Analytics Partners with IMPACT Solutions


The #AIEye: #IBMWatson ( $IBM) Health Publishes Top 100 Hospitals List, NICE Expands Partnership with ABBYY and MYnd Analytics Partners with IMPACT Solutions

Global #AI in Construction to Reach $3.161 Billion with CAGR of 38.14% by 2024



Point Roberts WA, Vancouver BC – March 4, 2019  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Global AI in Construction to Reach $3.161 Billion with CAGR of 38.14% by 2024

Zion Market Research has published a report on the global AI in construction market in the forecast period 2018-2024. The report indicates that the market will grow to $3.161 billion USD by 2024 with a compound annual growth rate (CAGR) of 38.14 percent. An excerpt from the report summary reads:

AI’s capability in construction services and solutions to reduce production costs is the major factor expected to drive the global AI-In-Construction market. In addition, the need for safety measures on construction sites is also projected to drive this market’s growth. Furthermore, huge investments made by construction companies from the emerging economies globally in the adoption of the advanced AI technology for construction applications is also likely to contribute toward the global growth of the AI-In-Construction market. However, the low technological investments in R&D for developing new technologies might hamper this market. Nonetheless, the increasing demand for integrated AI in construction activities is estimated to create new market opportunities.


IBM Watson Health Publishes Top 100 Hospitals List, NICE Expands Partnership with ABBYY and MYnd Analytics Partners with IMPACT Solutions

Stocks discussed: (NYSE:IBM) (NasdaqGS:NICE) (NasdaqCM:MYND)

IBM Watson Health (NYSE:IBM) has published its annual list of the top 100 performing hospitals in the U.S. According to the press release, the “study found that the top-performing hospitals in the country achieved better risk-adjusted outcomes while maintaining both a lower average cost per patient and higher profit margin than peer group hospitals that were part of the study.” Kyu Rhee, M.D., M.P.P., vice president and chief health officer at IBM Watson Health said:

“In this era of big data, analytics, transparency, and patient empowerment, it is essential that we learn from these leading hospitals and work to spread their best practices to our entire health system which could translate into over 100K more lives saved, nearly 40K less complications, over 150K fewer readmissions, and over $8 billion in savings."

NICE Ltd. (NasdaqGS:NICE) and its Robotic Process Automation (RPA) platform is incorporating additional AI capabilities to better process unstructured data, according to an announcement today. The company also expanded its partnership with AI solutions company ABBYY, contributing to its comprehensive digital transformation. Barry Cooper, President, NICE Enterprise Group, said:

“We are pleased to expand our partnership with ABBYY and to offer customers the most innovative, wide-ranging document processing solution that uniquely aligns with NEVA, the market's first employee focused attendant, to offer desktop assistance as well as our unattended robots that automate tasks in the back end. Enriching content and document processing with greater cognitive intelligence goes a long way in making interactions memorable while also offering greater operational efficiencies. Via this integration, our customers are empowered to improve business performance and ROI while delivering uncompromising customer experiences.”

MYnd Analytics, Inc., (NasdaqCM:MYND) a telemedicine and data analytics and augmented intelligence leader and Arcadian Telepsychiatry Services, have partnered with IMPACT Solutions, a leading provider of behavior healthcare and Employee Assistance Programs (EAP). The partnership will see the companies providing tele-EAP services to clients. Dr. Joel R. Gecht, President and CEO of IMPACT Solutions said:

“Tele-EAP provides our customers’ employees a convenient solution from the convenience of home using web-enabled video conferencing.  In turn, we believe these services will help increase employee participation and we can help both the employers and employees address potential problems before they affect work performance, health, or well-being.”


Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member




About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, contents creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: More disclaimer info: shttps://www.investorideas.com/About/Disclaimer.asp ,
Learn more about our podcast and article services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com
800 665 0411

No comments:

Post a Comment